Inhibrx Biosciences, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin -13,318.00%843,787.00%
EBIT Margin -12,178.94%-165,724.00%
EBITDA Margin -12,178.94%-165,724.00%
Operating Margin -12,178.94%-165,724.00%
Net Margin -13,318.17%843,786.00%
FCF Margin -10,994.56%-98,503.00%
Efficiency
Assets Average 244.33M
Equity Average 88.54M
Invested Capital 43.50M133.58M
Asset Utilization Ratio 0.00
Leverage & Solvency
Interest Coverage Ratio -6.89-24.57
Debt to Equity 4.76
Debt Ratio 0.67
Equity Ratio 0.140.74
Times Interest Earned -6.89-24.57
Valuation
Enterprise Value -277.92M70.33M
Market Capitalization 222.93M
Return Ratios
Return on Sales -133.18%
Return on Capital Employed -1.63%
Return on Invested Capital -3.74%
Return on Assets 6.91%
Return on Equity 19.06%